![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » DR. REDDY'S WILL SELL ULCER DRUG IN U.S.
DR. REDDY'S WILL SELL ULCER DRUG IN U.S.
Dr. Reddy's Laboratories, India's third-largest drugmaker, has received initial approval from the FDA to sell a drug used to treat ulcers in the U.S.
The approval covers 20-mg tablets of Famotidine, a drug used to treat ulcers, gastroesophageal reflux disease and conditions where the stomach produces too much acid.
KEYWORDS Drug Pipeline Alert
Upcoming Events
-
21Oct